Condition: Hypertension, Resistant to Conventional Therapy · Sponsor: neuroloop GmbH
The goal of this clinical trial is to learn weather the baroloop system is safe and works to treat hypertension in adults that do not respond sufficiently to medication. The main questions it aims to answer are: * Is the baroloop device associated with any major medical problems including death? * Does the baroloop lower the blood pressure of study participants? Participants will be implanted with the baroloop device. Afterwards they will visit the clinic after 14 days, 3 months, 6 months, 12 months, 18 months, and 24 months for adjustment of the device settings and/or other study related assessments. Participants will also be asked to answer questions regarding their quality of life.
This description comes directly from the study's public registry record.
Medical Scientific Affairs · +49 761 1543390 · study@neuroloop.de
Always discuss trial participation with your own doctor first.
| Clemenshospital Münster | Münster, North Rhine-Westphalia, Germany | Recruiting |
| Marienhaus Klinikum Mainz | Mainz, Rhineland-Westphalia, Germany | Recruiting |
| Städtisches Klinikum Dresden | Dresden, Saxony, Germany | Recruiting |
| UMC Utrecht | Utrecht, Utrecht, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06518915